Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025 - Top-Institutions - MDSpire

Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025

  • By

  • Muluken Belachew Mengistie

  • Wubete Lule Ayalew

  • Simane Kefale Mengistie

  • Ayenew Sisay Gebeyehu

  • Sefefe Birhanu Tizie

  • Ashagrie Anteneh Mekonen

  • Mezigebu Lule Ayalew

  • February 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gynecologic Oncology
    • Infectious Disease Epidemiology
    • Global Health

  • #2

    University of Cape Town
    University of Cape Town

    Cape Town, Western Cape

    Key Differentiators

    • Gynecologic Oncology
    • HIV Research
    • Epidemiology

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cancer Epidemiology
    • Infectious Diseases
    • Global Oncology

  • #4

    University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill

    Chapel Hill, NC

    Key Differentiators

    • Global Health
    • Gynecologic Oncology
    • Infectious Disease Epidemiology

  • #5

    Addis Ababa University
    Addis Ababa University

    Addis Ababa, Oromia

    Key Differentiators

    • Gynecologic Oncology
    • Public Health
    • Infectious Diseases

Original Source(s)

Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025

  • by Muluken Belachew Mengistie, Wubete Lule Ayalew, Simane Kefale Mengistie, Ayenew Sisay Gebeyehu, Sefefe Birhanu Tizie, Ashagrie Anteneh Mekonen, Mezigebu Lule Ayalew

  • February 28, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation